← Back to Search

Antiepileptic

Wait control for Hemoglobinopathy

Phase 1
Waitlist Available
Led By A.M. Barrett, MD
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
All Individual Drugs Already Approved
Approved for 5 Other Conditions
No Placebo-Only Group

Summary

This trial looks at whether the drug levetiracetam can help improve symptoms in people who have chronic aphasia due to a stroke.

Eligible Conditions
  • Hemoglobinopathy
  • Stroke
  • Aphasia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 5 Other Conditions
This treatment demonstrated efficacy for 5 other conditions.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Wait controlExperimental Treatment1 Intervention
Levitiracetam is started after a delay, with dosage and administration as described below.
Group II: Treatment firstExperimental Treatment1 Intervention
Levitiracetam is started immediately after baseline data is collected; dosage and administration as described below.

Find a Location

Who is running the clinical trial?

Kessler FoundationLead Sponsor
181 Previous Clinical Trials
11,029 Total Patients Enrolled
UCB PharmaIndustry Sponsor
342 Previous Clinical Trials
109,281 Total Patients Enrolled
A.M. Barrett, MDPrincipal InvestigatorKessler Foundation
1 Previous Clinical Trials
12 Total Patients Enrolled
~2 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top